|
"liu c h"的相關文件
顯示項目 1071-1080 / 1570 (共157頁)
<< < 103 104 105 106 107 108 109 110 111 112 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2020 |
Pioglitazone and PPAR-γmodulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: A national cohort study
|
Liu, C.-H.;Lee, T.-H.;Lin, Y.-S.;Sung, P.-S.;Wei, Y.-C.;Li, Y.-R. |
| 國立成功大學 |
2020 |
The Impact of Antiplatelet Use on the Risk of Intracerebral Hemorrhage in Patients with Alzheimer's Disease: A Nationwide Cohort Study
|
Lee, T.-L.;Liu, C.-H.;Chang, Y.-M.;Lin, T.-Y.;Chien, Chien C.-Y.;Chen, Chen C.-H.;Tsai, K.-J.;Lin, S.-H.;Sung, P.-S. |
| 國立成功大學 |
2020 |
Shrimp SIRT1 activates of the WSSV IE1 promoter independently of the NF-κB binding site
|
Kao, Z.-N.;Liu, C.-H.;Liu, W.-J.;Kumar, R.;Leu, J.-H.;Wang, H.-C. |
| 國立成功大學 |
2020 |
Smoking Paradox in Stroke Survivors?: Uncovering the Truth by Interpreting 2 Sets of Data
|
Wang, H.-K.;Huang, C.-Y.;Sun, Y.-T.;Li, J.-Y.;Chen, Chen C.-H.;Sun, Y.;Liu, C.-H.;Lin, C.-H.;Chang, W.-L.;Lee, J.-T.;Sung, Sung S.-F.;Yeh, P.-Y.;Lai, T.-C.;Tsai, I.-J.;Lin, M.-C.;Lin, C.-L.;Wen, C.-P.;Hsu, C.Y. |
| 國立成功大學 |
2020 |
Maintenance of stroke care quality amid the coronavirus disease 2019 outbreak in Taiwan
|
Chen, Chen C.-H.;Liu, C.-H.;Chi, N.-F.;Sung, P.-S.;Hsieh, C.-Y.;Lee, M.;Tang, S.-C.;Jeng, Jeng J.-S.;Investigators, Taiwan Stroke Society |
| 國立成功大學 |
2020 |
Extrahepatic Malignancy among Patients with Chronic Hepatitis C after Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Huang, C.-F.;Lai, H.-C.;Chen, Chen C.-Y.;Tseng, K.-C.;Kuo, H.-T.;Hung, C.-H.;Wang, J.-H.;Chen, J.-J.;Lee, P.-L.;Chien, R.-N.;Yang, C.-C.;Lo, G.-H.;Tai, C.-M.;Lin, C.-W.;Kao, J.-H.;Liu, C.-J.;Liu, C.-H.;Yan, S.-L.;Bair, M.-J.;Lin, C.-Y.;Su, W.-W.;Chu, Chu C.-H.;Chen, Chen C.-J.;Tung, S.-Y.;Lo, C.-C.;Cheng, P.-N.;Chiu, Y.-C.;Wang, C.-C.;Cheng, J.-S.;Tsai, W.-L.;Lin, H.-C.;Huang, Y.-H.;Yeh, M.-L.;Huang, J.-F.;Dai, C.-Y.;Chuang, W.-L.;Tsai, P.-C.;Peng, C.-Y.;Yu, M.-L. |
| 國立成功大學 |
2020 |
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
|
Hsu, W.-F.;Chen, Chen C.-Y.;Tseng, K.-C.;Lai, H.-C.;Kuo, H.-T.;Hung, C.-H.;Tung, S.-Y.;Wang, J.-H.;Chen, J.-J.;Lee, P.-L.;Chien, R.-N.;Lin, C.-Y.;Yang, C.-C.;Lo, G.-H.;Tai, C.-M.;Lin, C.-W.;Kao, J.-H.;Liu, C.-J.;Liu, C.-H.;Yan, S.-L.;Bair, M.-J.;Su, W.-W.;Chu, Chu C.-H.;Chen, Chen C.-J.;Lo, C.-C.;Cheng, P.-N.;Chiu, Y.-C.;Wang, C.-C.;Cheng, J.-S.;Tsai, W.-L.;Lin, H.-C.;Huang, Y.-H.;Tsai, P.-C.;Huang, J.-F.;Dai, C.-Y.;Chuang, W.-L.;Yu, M.-L.;Peng, C.-Y. |
| 國立成功大學 |
2020 |
Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis c patients: A nationwide real-world Taiwanese cohort (T-COACH)
|
Tsai, P.-C.;Chen, Chen C.-Y.;Kuo, H.-T.;Hung, C.-H.;Tseng, K.-C.;Lai, H.-C.;Peng, C.-Y.;Wang, J.-H.;Chen, J.-J.;Lee, P.-L.;Chien, R.-N.;Yang, C.-C.;Lo, G.-H.;Kao, J.-H.;Liu, C.-J.;Liu, C.-H.;Yan, S.-L.;Bair, M.-J.;Lin, C.-Y.;Su, W.-W.;Chu, Chu C.-H.;Chen, Chen C.-J.;Tung, S.-Y.;Tai, C.-M.;Lin, C.-W.;Lo, C.-C.;Cheng, P.-N.;Chiu, Y.-C.;Wang, C.-C.;Cheng, J.-S.;Tsai, W.-L.;Lin, H.-C.;Huang, Y.-H.;Yeh, M.-L.;Huang, C.-F.;Hsieh, M.-H.;Huang, J.-F.;Dai, C.-Y.;Chung, W.-L.;Ke, C.-L.K.;Yu, M.-L.;Group, T-COACH Study |
| 國立成功大學 |
2020 |
Neuroinflammation and neurogenesis in alzheimer’s disease and potential therapeutic approaches
|
Sung, P.-S.;Lin, P.-Y.;Liu, C.-H.;Su, H.-C.;Tsai, K.-J. |
| 國立成功大學 |
2020 |
Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis
|
Pai, C.-H.;Lin, S.-R.;Liu, C.-H.;Pan, S.-Y.;Hsu, Hsu H.;Chen, Y.-T.;Yen, C.-T.;Yu, I.-S.;Wu, H.-L.;Lin, S.-L.;Lin, S.-W. |
顯示項目 1071-1080 / 1570 (共157頁)
<< < 103 104 105 106 107 108 109 110 111 112 > >>
每頁顯示[10|25|50]項目
|
